GlaxoSmithKline (GSK) has confirmed that CEO Emma Walmsley will step down from her position, effective immediately. Chief Commercial Officer Luke Miels will succeed her...
Dynavax Technologies Corporation has reported that its experimental shingles vaccine demonstrates an immune response comparable to that of GSK’s well-established vaccine, Shingrix. This finding...
BioNTech has reached a settlement in a three-year patent dispute involving mRNA technology with GlaxoSmithKline (GSK) and CureVac. As part of this agreement, both...